S. Shah

Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial

A. Mahajan, N. Mummudi, K. Prabhash, 2022, Esophagus.

An observational study to evaluate factors predicting survival in patients of non-small cell lung cancer with poor performance status in resource-constrained settings

A. Mahajan, K. Prabhash, V. Noronha, 2021, Ecancermedicalscience.

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer.

A. Dutt, Rajiv Kumar, A. Mahajan, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial

A. Mahajan, N. Mummudi, K. Prabhash, 2022, Esophagus.

Aprepitant for Cough Suppression in Advanced Lung Cancer: A Randomized Trial.

S. Kannan, A. Bhattacharjee, K. Prabhash, 2020, Chest.

Deviation from standard cancer treatment during the first wave of the COVID-19 pandemic in India: A cross-sectional study

K. Prabhash, V. Noronha, V. Patil, 2022, Cancer Research, Statistics, and Treatment.

The role of chemotherapy in patients with small cell lung cancer and poor performance status

A. Mahajan, K. Prabhash, V. Noronha, 2020, Acta oncologica.

Clinical Outcome in Definitive Concurrent Chemoradiation With Weekly Paclitaxel and Carboplatin for Locally Advanced Esophageal and Junctional Cancer

A. Mahajan, S. Ghosh-Laskar, K. Prabhash, 2016, Oncology research.